The 2nd Spanish-Portuguese Local Chapter- Controlled Release Society (SPLC-CRS) Young Scientists Meeting was held on January 23that Santiago de Compostela, and it was a great success!
The congress was opened by Prof. Dolores Torres (SPLC-CRS President, University of Santiago de Compostela (USC), Spain) and Prof. Maria José Alonso (CRS President,USC, Spain) before an audience of about 80 persons. They highlighted the challenges and opportunities within the SPLC-CRS and the CRS, including the active engagement of the industrial partners.
Prof. Maria Jesus Vicent (Chair of the 46thCRS Annual Meeting & Exposition, Centro de Investigación Príncipe Felipe, Valencia) presented the Scientific Program of the next CRS Annual meeting, next July in Valencia, and why this is a must-attend science event!
Prof. Marta Vives-Pi (Universitat Autònoma de Barcelona, Spain) and João Mano (CICECO - Aveiro Institute of Materials University of Aveiro, Portugal) were the invited speakers and shared with the participants their extraordinary contribution to the field of nanomedicines and controlled drug delivery.
The Board of the CRS-Spanish Portuguese Local Chapter thanks all the youngs scientist participants for their exciting talks and stimulating discussions with the attendees!
Congratulations to the 2nd Spanish SPLC-CRS Young Scientists Meeting Awardees!! The best oral presentation awards were received by Ana Olivera (CIMUS, University of Santiago de Compostela) and Flávia Sousa (i3S, University of Porto, Portugal). Filipa Fonseca (i3S, University of Porto, Portugal) and Cristian Reboredo (University of Navarra, Spain) received the awards for the best poster communications.
- Ana Olivera
“Polymeric nanocapsules as a novel tolerogenic treatment for Type 1 Diabetes”
Ana Olivera is a 4th year PhD candidate at Maria Jose Alonso’s laboratory at the University of Santiago de Compostela (USC), Spain. She has a Bsc in Biochemistry by the Autonomous University of Madrid (UAM), and a Msc in Drug Development by the USC.
- Flavia Sousa
“Nanoencapsulated Bevacizumab Inhibits Glioblastoma Vascularization via Intratumoral VEGF Trapping”
Flávia Sousa is a 4th year PhD candidate at Bruno Sarmento's laboratory at the Instituto de Investigação e Inovação em Saúde (I3s), University of Porto, Portugal. She has a BsC and Msc in Pharmaceutical Sciences at the Instituto Universitário de Ciências da Saude, Porto, Portugal.
- Filipa Fonseca
“Establishment of bioengineered glucose-responsive nanoparticles for type 2 diabetes mellitus therapy”
Filipa Fonseca is graduated in Biochemistry at Faculty of Sciences and Technology from New University of Lisbon (FCT/UNL) and she is now on the 2nd year of her master in Biochemistry for Health, a collaboration between FCT, Instituto de Tecnologia Química e Biológica (ITQB) and Faculty of Medical Sciences (FCM) from UNL. Currently, she is doing her master dissertation at Nanomedicines & Translational Drug Delivery group at Instituto de Investigação e Inovação para a Saúde (i3S).
- Cristian Reboredo
“Evaluation of mucus-permeating nanocarriers for the oral delivery of proteins”
Cristian Reboredo is a 2nd year Ph. D. candidate at the Department of Chemistry and Pharmaceutical Technology at the University of Navarra (UNAV), under the supervision of Juan Manuel Irache. He has a Bsc in Biochemistry with a Research Training Programme mention in microbiology, and a Msc in Drug Research, Development and innovation by the UNAV
Ana Olivera receiving one of the awards for the best oral communication in the “2ndCRS-SPLC Young Scientists Meeting”, January 23th, Santiago de Compostela, Spain 2019.
Flavia Sousa receiving one of the awards for the best oral communication in the “2ndCRS-SPLC Young Scientists Meeting”, January 23th, Santiago de Compostela, Spain 2019.
Cristian Reboredo receiving one of the awards for the best poster presentation the “2ndCRS-SPLC Young Scientists Meeting”, January 23th, Santiago de Compostela, Spain 2019.